Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Dolby Laboratories (DLB) EBIAT (2016 - 2025)

Dolby Laboratories (DLB) has disclosed EBIAT for 17 consecutive years, with $53.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT fell 21.66% year-over-year to $53.3 million, compared with a TTM value of $241.0 million through Dec 2025, down 9.31%, and an annual FY2025 reading of $256.5 million, down 2.96% over the prior year.
  • EBIAT was $53.3 million for Q4 2025 at Dolby Laboratories, up from $49.7 million in the prior quarter.
  • Across five years, EBIAT topped out at $98.2 million in Q1 2024 and bottomed at $10.2 million in Q3 2023.
  • Average EBIAT over 5 years is $56.8 million, with a median of $54.0 million recorded in 2021.
  • The sharpest move saw EBIAT plummeted 63.09% in 2023, then surged 500.17% in 2024.
  • Year by year, EBIAT stood at $80.0 million in 2021, then decreased by 0.7% to $79.4 million in 2022, then decreased by 14.94% to $67.6 million in 2023, then rose by 0.72% to $68.1 million in 2024, then fell by 21.66% to $53.3 million in 2025.
  • Business Quant data shows EBIAT for DLB at $53.3 million in Q4 2025, $49.7 million in Q3 2025, and $46.5 million in Q2 2025.